0001161697-23-000643.txt : 20231229
0001161697-23-000643.hdr.sgml : 20231229
20231229170020
ACCESSION NUMBER: 0001161697-23-000643
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231227
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Del Carmen Jeffrey
CENTRAL INDEX KEY: 0001816477
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 231528392
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 12-27-2023
X0508
4
2023-12-27
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001816477
Del Carmen Jeffrey
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Commercial Officer
0
Common stock, par value $0.001 per share
2023-12-27
4
M
0
8666
A
22265
D
Common stock, par value $0.001 per share
2023-12-27
4
F
0
3839
D
18426
D
Restricted Stock Units
2023-12-27
4
M
0
8666
0
D
Common Stock
8666
844686
D
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 27, 2023.
/s/ Jeffrey Del Carmen
2023-12-29